Nasal Decongestant Pe Tablet
NDC Package 69168-272-82

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Other Packages
    3. Frequently Asked Questions

Package Information

Nasal Decongestant Pe (phenylephrine 10 mg) tablets is take every 4 to 6 hours do not take more than 6 doses in 24 hoursAdults and children 12 years of age and older:1 tabletChildren under 12 years of age: Consult a doctor. This formulation utilizes a tablet delivery system. Marketed by Allegiant Health, this product is identified by NDC 69168-272 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
69168-272-82
Package Description
90 TABLET in 1 BOTTLE
Product Code
69168-272
11-Digit Billing Format
69168027282
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Nasal Decongestant Pe Maximum Strength Non-drowsy
Non-Proprietary Name
Phenylephrine 10 Mg
Substance Name
Phenylephrine Hydrochloride
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
PHENYLEPHRINE HYDROCHLORIDE 10 mg/1
Pharmacologic Class
Usage Information
take every 4 to 6 hours do not take more than 6 doses in 24 hoursAdults and children 12 years of age and older:1 tabletChildren under 12 years of age: Consult a doctor

Regulatory & Marketing

Labeler Name
Allegiant Health
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
12-23-2014
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Other Available Packages

The following commercial packages are registered under the same Product NDC (69168-272). Click a package code to view its specific billing and regulatory data.

69168-272-17
300 TABLET in 1 BOTTLE
69168-272-93
1 BLISTER PACK in 1 CARTON / 24 TABLET in 1 BLISTER PACK

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69168-272-82 identifies a specific commercial package of 90 tablet in 1 bottle of Nasal Decongestant Pe Maximum Strength Non-drowsy, a human over the counter drug labeled by Allegiant Health. This tablet is formulated for oral use and contains phenylephrine hydrochloride as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Allegiant Health on December 23, 2014. The current certification is valid through December 31, 2026.

How is this Allegiant Health product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69168027282. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69168-272-82
11-Digit CMS (5-4-2)
69168-0272-82

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.